Brian Halak - Profile and Investment Details

Investor Profile

Brian Halak is a Venture Capital, Private Equity Firm, Investment Partner, Investor based in Wayne, Pennsylvania, United States with a diverse investment portfolio that includes companies such as Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical, Exalys Therapeutics, WindMIL Therapeutics, Zyga TechnologyAtara Biotherapeutics, VentiRx Pharmaceuticals, Celtaxsys, Truvian Sciences, Gene Sciences, Inc., Kona Medical, Vanda Pharmaceuticals, Veracyte, CoLucid Pharmaceuticals, Dicerna Pharmaceuticals, NovaDigm Therapeutics, Benvenue Medical, Miramar Labs, Ocunexus Therapeutics, Cotera, Regado Biosciences, Obalon Therapeutics, Sequent Medical, Marinus Pharmaceuticals, Eddingpharm (Cayman), ReVision Optics, Neothetics, Esprit Pharma, Aspen Neuroscience, Sera Prognostics, Afferent Pharmaceuticals, Carticept Medical, Sebacia, Omniome, Xagenic, Fractyl Laboratories, Axial Biotherapeutics, Seraphina Therapeutics, Corridor Pharmaceuticals, ChromaCode, Achaogen, Milestone Pharmaceuticals, Evofem Biosciences, Applied Proteomics, Apnex Medical, Bionano Genomics, Alimera Sciences, Smart Medical Systems, Twelve, Nobias Therapeutics, RightCare Solutions, Antios Therapeutics, Adynxx, Tandem Diabetes Care, Immunitas Therapeutics, Glaukos, Oraya Therapeutics, Otonomy, Singular Genomics, aTyr Pharma, ROX Medical, Iterum Therapeutics, Syndax Pharmaceuticals, . Over time, Brian Halak has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Brian Halak is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Women Founded, Fundraising, Investment Management, Life Science, Portfolio Management, Education, Finance, Biotechnology, Medical Devices, Market Research, Reviews and Recommendations, Consulting, Mergers and Acquisitions, Health Diagnostics, Digital Health, Higher Education, Medical, Big Data, B2B, Therapeutics, Financial Advisory, Media and Entertainment, Pharmaceuticals, Risk Management, Acquisitions may find it worthwhile to explore potential connections with Brian Halak, as their portfolio suggests a familiarity and interest in this area.

Understanding Brian Halak’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.